Literature DB >> 26097064

PEGylation to Improve Protein Stability During Melt Processing.

Parker Lee1, Jenna Towslee1, João Maia1, Jonathan Pokorski2.   

Abstract

Biopharmaceuticals are some of the most effective drugs on the market, however, delivery remains a challenge. Melt processing is a viable protein encapsulation method because it is solvent free, is high throughput, and yields very high encapsulation efficiencies. Problematically, proteins can lose activity during melt processing due to high heat and shear forces. Covalent attachment of poly(ethylene glycol), or PEGylation, has been widely used to increase thermal stability and prevent aggregation in solution. This study explored the effect of PEGylation on protein stability during melt processing using lysozyme and PLGA. The results indicate that PEGylation increases the retained activity of lysozyme, increases dispersion in the melt, and reduces the biphasic release profile in melt processed systems.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  PEGylation; melt processing; poly(lactic-co-glycolic acid); protein stability

Mesh:

Substances:

Year:  2015        PMID: 26097064      PMCID: PMC4615555          DOI: 10.1002/mabi.201500143

Source DB:  PubMed          Journal:  Macromol Biosci        ISSN: 1616-5187            Impact factor:   4.979


  38 in total

1.  Therapeutic antibody fragments with prolonged in vivo half-lives.

Authors:  A P Chapman; P Antoniw; M Spitali; S West; S Stephens; D J King
Journal:  Nat Biotechnol       Date:  1999-08       Impact factor: 54.908

2.  The conformation of the poly(ethylene glycol) chain in mono-PEGylated lysozyme and mono-PEGylated human growth hormone.

Authors:  Sheetal S Pai; Boualem Hammouda; Kunlun Hong; Danilo C Pozzo; Todd M Przybycien; Robert D Tilton
Journal:  Bioconjug Chem       Date:  2011-10-06       Impact factor: 4.774

3.  Low temperature extruded implants based on novel hydrophilic multiblock copolymer for long-term protein delivery.

Authors:  Milica Stanković; Hans de Waard; Rob Steendam; Christine Hiemstra; Johan Zuidema; Henderik W Frijlink; Wouter L J Hinrichs
Journal:  Eur J Pharm Sci       Date:  2013-05-23       Impact factor: 4.384

4.  Improved intestinal delivery of salmon calcitonin by water-in-oil microemulsions.

Authors:  Yating Fan; Xinru Li; Yanxia Zhou; Chao Fan; Xiaoning Wang; Yanqing Huang; Yan Liu
Journal:  Int J Pharm       Date:  2011-06-24       Impact factor: 5.875

5.  Rational design of a potent, long-lasting form of interferon: a 40 kDa branched polyethylene glycol-conjugated interferon alpha-2a for the treatment of hepatitis C.

Authors:  P Bailon; A Palleroni; C A Schaffer; C L Spence; W J Fung; J E Porter; G K Ehrlich; W Pan; Z X Xu; M W Modi; A Farid; W Berthold; M Graves
Journal:  Bioconjug Chem       Date:  2001 Mar-Apr       Impact factor: 4.774

6.  Protein release from poly(lactide-co-glycolide) implants prepared by hot-melt extrusion: thioester formation as a reason for incomplete release.

Authors:  Zahra Ghalanbor; Martin Körber; Roland Bodmeier
Journal:  Int J Pharm       Date:  2012-09-16       Impact factor: 5.875

7.  Biopharmaceutical benchmarks 2014.

Authors:  Gary Walsh
Journal:  Nat Biotechnol       Date:  2014-10       Impact factor: 54.908

8.  Biochemical and biophysical characterization of lysozyme modified by PEGylation.

Authors:  Débora da Silva Freitas; José Abrahão-Neto
Journal:  Int J Pharm       Date:  2010-03-20       Impact factor: 5.875

9.  Adsorption of poly(ethylene glycol)-modified lysozyme to silica.

Authors:  Susan M Daly; Todd M Przybycien; Robert D Tilton
Journal:  Langmuir       Date:  2005-02-15       Impact factor: 3.882

10.  Improved lysozyme stability and release properties of poly(lactide-co-glycolide) implants prepared by hot-melt extrusion.

Authors:  Zahra Ghalanbor; Martin Körber; Roland Bodmeier
Journal:  Pharm Res       Date:  2009-12-23       Impact factor: 4.200

View more
  5 in total

1.  Modelling of electrokinetic phenomena for capture of PEGylated ribonuclease A in a microdevice with insulating structures.

Authors:  Marco A Mata-Gomez; Victor H Perez-Gonzalez; Roberto C Gallo-Villanueva; Jose Gonzalez-Valdez; Marco Rito-Palomares; Sergio O Martinez-Chapa
Journal:  Biomicrofluidics       Date:  2016-06-15       Impact factor: 2.800

2.  Milling solid proteins to enhance activity after melt-encapsulation.

Authors:  Parker W Lee; João Maia; Jonathan K Pokorski
Journal:  Int J Pharm       Date:  2017-09-20       Impact factor: 5.875

3.  Biodegradable Viral Nanoparticle/Polymer Implants Prepared via Melt-Processing.

Authors:  Parker W Lee; Sourabh Shukla; Jaqueline D Wallat; Chaitanya Danda; Nicole F Steinmetz; Joao Maia; Jonathan K Pokorski
Journal:  ACS Nano       Date:  2017-09-13       Impact factor: 15.881

4.  Site-specific PEGylation of micro-plasmin for improved thrombolytic therapy through engineering enhanced resistance against serpin mediated inhibition.

Authors:  Navneet Kaur; Prakash Kumar Sinha; Girish Sahni
Journal:  PLoS One       Date:  2019-05-29       Impact factor: 3.240

5.  Interleukin-10 Conjugation to Carboxylated PVP-Coated Silver Nanoparticles for Improved Stability and Therapeutic Efficacy.

Authors:  Dieudonné R Baganizi; Elijah Nyairo; Skyla A Duncan; Shree R Singh; Vida A Dennis
Journal:  Nanomaterials (Basel)       Date:  2017-07-02       Impact factor: 5.076

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.